CIDRAP newsletters options
A study published today in Pediatrics shows Chinese children who contracted COVID-19 often presented with co-infections of other respiratory viruses.
The man was treated on Dec 27, 2019—4 days before a COVID-19 cluster was identified in Wuhan, China.
Of those polled, 78% say they would be uncomfortable in a sit-down restaurant.
Cases rose 41% in Africa last week, and transmission is widespread in 7 countries. Lesotho is the only nation that hasn't reported a case.
US drug maker Pfizer Inc. and Germany biopharmaceutical company BioNTech announced today that the first US participants in a clinical trial for a novel coronavirus vaccine have begun receiving doses.
The report seeks to bridge the gap between current practice and the need to protect health workers.
Leaked White House documents say deaths will climb to 3,000 a day by Jun 1.
Nations and groups pledge $8 billion to make the ACT Accelerator a reality.
The Food and Drug Administration (FDA) today said that it's revising a policy that aimed to accelerate the availability of COVID-19 antibody tests in the wake of reports that some companies have been marketing fraudulent tests.
Spain, the world's second hardest-hit country after the US, is taking cautious steps to ease its 7-week lockdown, while the US CDC launches a gene tracking consortium to help with response.
Experts urge the WHO to develop guidance for the gradual return of passenger travel.
COVID-19 meat plant outbreaks have been noted in at least 5 Midwestern states.
Among the challenges highlighted in the report are limited data and lack of timely information.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The Global Antibiotic Research and Development Partnership (GARDP) this week announced a partnership with Venatorx Pharmaceuticals to accelerate development of an investigational beta-lactam/beta-lactamase inhibitor combination for treating multidrug-resistant hospital infections.
Though many organization have published guidance on the best way forward during this COVID-19 pandemic, the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota saw a need for recommendations based on current realities and restrictions, not on technology such as widespread testing that may one day be in place.
The opening of states is now in the hands of governors.
COVID-19 infected and killed more people in poor, ethnically diverse areas than in affluent, less diverse ones.
The study provides clear evidence of the power of childhood vaccines on reducing the antibiotic resistance burden.
The UK will release a plan to begin loosening restrictions next week.
